Nuclear Medicine/Radiopharmaceuticals Market

Demand for Nuclear Medicine/Radiopharmaceuticals is expected to surge at a CAGR of 20.1% during the forecast period – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 23, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Nuclear Medicine/Radiopharmaceuticals Market is estimated to expand USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 22, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Global Sales of Nuclear Medicine/Radiopharmaceuticals are projected to top a valuation of USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 19, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Nuclear Medicine/Radiopharmaceuticals Sales are slated to surge at USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 18, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by 2032, at …

Valuation of Nuclear Medicine/Radiopharmaceuticals is expected to grow at USD 48.8 billion by 2032 – Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging

May 11, 2023 by Global Insight Services

The global nuclear medicine/radiopharmaceuticals market was valued at USD 7.8 billion in 2022 and it is anticipated to grow up to USD 48.8 billion by …

Reach out to us for a consultation.